Phase 2
N=108
Pilot Trial of Preoperative Chlorhexidine Gluconate (CHG) Skin Preparation
Surgery
Bottom Line
View on ClinicalTrials.gov: NCT02530528 ↗Enrolled (actual)
108
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcome: Primary: Log Reduction of Bacterial Flora on Abdomen and Groin Sites — 2.6; 3.4; 2.7; 4.2 Log 10 Reduction
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- CHG (Drug)
- Age
- Pediatric, Adult, Older Adult · 16+ yrs
- Sex
- All
- Sponsor
- Medline Industries
- Primary completion
- Apr 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Log Reduction of Bacterial Flora on Abdomen and Groin Sites |
2.6; 3.4; 2.7; 4.2; 2.8; 4.3 | — |
Summary
Pilot study to evaluate and compare activity of investigational preoperative preparation (2% CHG) with comparator (2% CHG).
Eligibility Criteria
Inclusion Criteria
- Healthy
- No dermatological conditions
Exclusion Criteria
- Sensitivity to CHG
- Sensitivity to natural latex rubber or adhesive skin products
Data sourced from ClinicalTrials.gov (NCT02530528). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.